Is CEBPA p.Pro70= (c.210G>C) pathogenic?

CEBPA p.Pro70= (c.210G>C) is classified Likely benign in CEBPA (ClinVar, Single submitter, 1 submitter; last evaluated 2022-07-25). Absent from gnomAD v4.1; Associated with acute myeloid leukemia.

What condition is associated with CEBPA p.Pro70= (c.210G>C)?

CEBPA p.Pro70= (c.210G>C) is associated with acute myeloid leukemia (ClinVar).

How common is CEBPA p.Pro70= (c.210G>C) in the general population?

CEBPA p.Pro70= (c.210G>C) is absent from gnomAD v4.1 (gnomAD).

CEBPA p.Pro70=

c.210G>C · rs1432277634 · VCV1585097

Likely benign Single submitter

Classification

Likely benign

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

gnomAD v4.1

Not reported

no allele count reported in gnomAD v4.1 (AN 1,496,924)

Conditions

acute myeloid leukemia

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 0.72	GERP -1.1, phastCons 1
Overall
CADD	13.03	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

No allele count reported in gnomAD v4.1 (AN 1,496,924). This is missing data, not an absence: the variant may or may not be present in gnomAD. Rarity (ACMG PM2) and BA1/BS1 cannot be assessed for it.

Variant & gene context

Gene: CEBPA
Protein: p.Pro70=
Coding: c.210G>C
MANE Select: NM_004364
dbSNP: rs1432277634
Type: single nucleotide variant
Location: chr19:33302205 (GRCh38)
Gene constraint: LOEUF 1.372 · pLI 0.26 · ClinGen HI 0/3 (gnomAD)
Structure: AlphaFold pLDDT 63.67 · 2 PDB
Residue 70: the 'required to repress e2f1:tfdp1-mediated transcription, to inhibit cell cycle and to induce adipocyte differentiation' region; an α-helix; the 'required for interaction with trib1' region

Full CEBPA gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

acute myeloid leukemia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Similar variants

CEBPA p.Pro70Thr Uncertain significance ★★ ⚠ same residue
CEBPA p.Pro70Gln Uncertain significance ★ ⚠ same residue
CEBPA p.Pro70Leu Uncertain significance ★ ⚠ same residue
CEBPA p.Pro70fs Pathogenic ★ same residue
CEBPA p.Pro70Ser Uncertain significance ★ same residue
CEBPA p.Glu59Ter Pathogenic ★★ same condition
CEBPA p.Ala113Ser Uncertain significance ★★ ⚠ same condition
CEBPA p.Ala118Thr Uncertain significance ★★ ⚠ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cebpa-p-pro70 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown